IBRO Neuroscience Reports

Aims & Scope

IBRO Neuroscience Reports is an Open Access journal which publishes papers describing the results of original research on any aspect of the scientific study of the nervous system.

The journal welcomes preliminary, descriptive and small-scale results if they have the potential to stimulate and/or contribute to future research, leading to new insights or hypotheses.

The primary criterion for acceptance is that the work is original, scientifically and technically sound, and valuable to the advancement of neuroscience research.

IBRO Neuroscience Reports will consider for publication any article that is methodologically sound, including negative data.

Replication studies and re-analysis of previous datasets, when justified with a scientifically sound rationale, are also welcomed.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,400.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Molecular mechanisms underlying hyperglycemia associated cognitive decline

  Citation: 76

  Authors: Mrinal, Shivani, Mohammad, Babita, Abbas Ali

• Superoxide dismutase and neurological disorders

  Citation: 75

  Authors: Saravana Babu, Nikhilesh, Sudhir Rama, Srinivasan, Chandrasekaran, Ambika, Arehally M., Musthafa Mohamed

• Ensemble learning using traditional machine learning and deep neural network for diagnosis of Alzheimer’s disease

  Citation: 62

  Authors: Dong, Hoang, Hong, Hoang, Huong, Nguyen Thanh, Hoan Thanh

• Depression in Sub-Saharan Africa

  Citation: 61

  Authors: Ismail Temitayo, Isaac Tabiri, Oritoke Modupe, Emmanuel Olusola, Aliance Romain, Awo, Joseph, Samson Ehindero, Folashade Susan, Yusuf, Salmat Temilola, Robert Peter, Thomas Amatey

• The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders

  Citation: 58

  Authors: Yousef, Ameneh, Amber, Shiva Gholizadeh-Ghaleh, Sepideh, Ladan, Faeze, Shahriar

• A deep learning framework integrating MRI image preprocessing methods for brain tumor segmentation and classification

  Citation: 47

  Authors: Khiet, Toi, Lua, Huong

• Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model

  Citation: 35

  Authors: Marcos K., Leonardo C., Evellyn M., Ellen L., Silvio M., Roberto, Maria A.B.F.

• Mechanistic considerations and biomarkers level in nickel-induced neurodegenerative diseases: An updated systematic review

  Citation: 33

  Authors: Chidinma Promise, Donatus Baridoo, Chinna Nneka, Cecilia Nwadiuto, Beatrice, Flavia, Marta, Chiara, Orish E.

• Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction

  Citation: 29

  Authors: Michael Kunle, Abayomi Oyeyemi, Oluwanisola Akanji, Akeem Ayodeji, Ahmad Adekilekun

• Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives

  Citation: 28

  Authors: Wael, Jaya, Badrah S., Al-Hassan, Yamashita